| Presented by: | The International AIDS Society-USA |
| Lecturer | David L. Wyles, MD and Steven C. Johnson, MD |
| Approximate duration: | Not available |
| Summary points: | This educational presentation uses interactive case studies to explain the impact of hepatic dysfunction on antiretroviral pharmacokinetics, the impact of antiretroviral therapy on the natural history of hepatitis C virus (HCV) infection, gives examples of important interactions between antiretroviral drugs and ribavirin, and identifies unique issues in liver transplantation for end-stage liver disease resulting from HCV infection in coinfected patients. |
| Accreditation: | The International AIDS Society-USA is accredited by the Accreditation Council for Continuing Medical Education to sponsor continuing medical education for physicians.
The International AIDS Society-USA designates this educational activity for a maximum of 1 AMA PRA Category 1 Credit.
Expiration Date: October 2, 2010. |
| Other: | Text-only CME. |
E-Mail this webcast/CME to a colleague
Issues in the Care of HIV and Hepatitis C Virus-coinfected Patients: Antiretroviral Pharmacokinetics, Drug Interactions, and Liver Transplantation
Go to webcast/CME
E-Mail this webcast/CME to a colleague
Remind me of this
